Corporate Updates

Roche to Develop Companion Diagnostic Test for Dalcetrapi

Views: 2.1K

Roche-62iqho39os8l6knqb75cb1et7b6isqcb4a3v2nhwusaRoche, a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics, has signed an agreement to develop a companion diagnostic (CDx) test for dalcetrapib, a therapeutic from DalCor Pharmaceuticals (DalCor).The CDx test being developed by Roche will be used in a phase III clinical trial, which will validate the clinical efficacy of dalcetrapib.

DalCor is initially focused on providing precision medicine to patients through identification of patient populations that derive clinical benefits. By integrating clinical and genetic insights, DalCor and its partners intend to deliver superior outcomes in clinical medicine.

“At Roche, we understand the importance of forging partnerships that make significant impacts on patient lives,” said Paul Brown, Head of Roche Molecular Diagnostics. “Our first companion diagnostic test in cardiovascular disease represents a significant innovation, and leverages our expertise in developing FDA approved CDx tests. Working with DalCor is a good opportunity for us to enter this market and deliver on our mission of personalized healthcare.”

“The possibility of reducing morbidity and mortality for patients who have experienced ACS by identifying genetic markers that can respond to therapy, is an exciting prospect and one that we are eager to be a part of,” said Robert McNeil, CEO, DalCor Pharmaceuticals. “The DalCor and Roche collaboration for the genetic testing is the right combination for successful execution of the phase III trial.”

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.



  1. internet speed

    April 17, 2018 at 7:13 pm

    I like the helpful information you provide in your articles. I will bookmark your blog and check again here regularly. I am quite sure I’ll learn many new stuff right here! Best of luck for the next!

  2. new business

    April 19, 2018 at 11:15 pm

    Nice blog here! Also your web site loads up very fast! What web host are you using? Can I get your affiliate link to your host? I wish my website loaded up as quickly as yours lol

  3. tworzenie stron gorzow

    April 21, 2018 at 9:47 pm

    I was reading through some of your articles on this website and I think this site is very instructive! Continue putting up.

  4. development

    April 27, 2018 at 3:20 am

    I’m very happy to read this. This is the kind of manual that needs to be given and not the random misinformation that is at the other blogs. Appreciate your sharing this greatest doc.

  5. Pozycjonowanie Gorzów Wielkoposki

    April 27, 2018 at 3:50 am

    I do trust all of the ideas you’ve introduced in your post. They’re very convincing and will definitely work. Still, the posts are too short for beginners. May just you please extend them a bit from subsequent time? Thanks for the post.

Leave a Reply

Your email address will not be published.

Most Popular

To Top